|Ms. Yana Popova CPA||CFO, Corp. Sec. & Director||N/A||N/A||1982|
|Mr. Darryl Jones||Pres, CEO & Director||N/A||N/A||1983|
|Mr. Matt Chatterton||Chief Operating Officer||N/A||N/A||N/A|
Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Isracann Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.